ONCOLOGY INSTITUTE INC/THE (TOI)

US68236X1000 - Common Stock

1.07  -0.09 (-7.76%)

After market: 1.11 +0.04 (+3.74%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
203M
8.27%		252.5M
24.38%		324.239M
28.41%		416.63M
28.49%
EBITDA
YoY % growth
-42.56M
-747.81%		-67.59M
-58.81%		-54.278M
19.70%		-13.736M
74.69%
EBIT
YoY % growth
-45.9M
-459.76%		-72M
-56.86%		-60.151M
16.46%		-19.004M
68.41%
Operating Margin
-22.61%-28.51%-18.55%-4.56%
EPS
YoY % growth
N/AN/A-0.69-0.36
47.30%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.12
-21.20%
Revenue
Q2Q % growth		96.117M
26.15%
EBITDA
Q2Q % growth		-5.656M
EBIT
Q2Q % growth		-7.013M
56.17%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.21
16.00%		-0.11-0.10-89.02%
Q3 2023
Q2Q % growth		 -0.19
24.00%		-0.13-0.06-44.71%
Q2 2023
Q2Q % growth		 -0.19 -0.17-0.02-10.66%
Q4 2022
Q2Q % growth		 -0.25 -0.18-0.07-37.51%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 85.788M
20.12%		82.862M2.926M3.53%
Q3 2023
Q2Q % growth		 82.04M
26.25%		75.411M6.629M8.79%
Q2 2023
Q2Q % growth		 80.22M
31.68%		74.527M5.693M7.64%
Q4 2022
Q2Q % growth		 71.42M
36.56%		65.398M6.022M9.21%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 7.69% 12.2%
RevenueN/A N/A 8.9% 9.53%